Research progress on intravascular treatment for acute ischemic stroke
10.3760/cma.j.issn.1008-6315.2020.01.020
- VernacularTitle: 急性缺血性卒中血管内治疗技术研究进展
- Author:
Qingfeng ZHU
1
;
Yixia ZHU
;
Qi SUN
;
Guofang WANG
Author Information
1. Department of Neurosurgery, the 985th Hospital of PLA, Taiyuan 030001, China
- Publication Type:Review
- Keywords:
Acute ischemic stroke;
Mechanical thrombectomy;
Devices;
Technology
- From:
Clinical Medicine of China
2020;36(1):87-91
- CountryChina
- Language:Chinese
-
Abstract:
The acute ischemic stroke has become the first major disability and death disease in China.With the release of the results of five trials represented by the Dutch multicenter randomized clinical trials of intravascular treatment of acute ischemic stroke, mechanical thrombectomy has become the main means to treat the acute ischemic stroke caused by the occlusion of large intracranial vessels, ushering in a new era of mechanical thrombectomy for acute cerebral infarction.At present, the main devices of mechanical thrombectomy are Merci thrombectomy device, penumbra thrombectomy device, solitairetm fr stent, revive se stent, trevo stent and aperio ® stent.According to the location and conditions of vascular embolism, different types of thrombectomy devices should be selected, and different thrombectomy technologies, such as adapt technology, solumbra Technology, advance technology, save technology, swim technology, etc So as to improve the recanalization rate and reduce complications.
